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CHAPTER I 
INTRODUCTION 
Congenital malformations suCh as cleft palate have been produced 
in laboratory animals by various modalities. Cleft palate in humans is 
a congenital defect that occurs approximately one in every eight hundred 
live births (Grace, 1943). This defect is the result of the failure of 
the palatine processes to meet and fuse during a specific time in embryo-
logical development. In untreated cases severe handicaps appear. Speech, 
mastication,· deglutition and respiration are affected and as a result 
psychologic problems develop. In 1940, Warkany and Nelson showed that 
nutritional disturbances were contributing factors to cleft palate pro-
duction. Fogh-Andersen (1942) demonstrated that genetic factors were 
also important. Strean and Peer (1956) thought that physiologic, emo-
tional or traumatic stress played a role in human clefts by stimulating 
the adrenal cortex to secrete hydrocortisone. This appeared to correlate 
with the animal studies of Baxter and Fraser (1950) , Fraser and Fainstat 
(1951), and Kalter (1957) who were able to_ produce clefts in mice before 
birth by giving cortisone to pregnant A/Jax mice. Experimental production 
of cleft palate with cortisone in inbred mice has provided a convenient 
and a reliable tool for investigation into the mechanism of congenital 
malformations. For over 20 years investigators have reported induction 
~ 
of cleft palates in the offspring of mice after maternal injection of 
. II 
~ 
corticoids. 
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Baxter et al (1950), and Fraser et al (1951) established that the 
offspring of A/Jax mice were 100% susceptible to cleft palate when mater-
nally injected with 2.5 mg. of cortisone acetate on day 11, 12, 13, and 
14 of gestation. Chaudhry and associates (1967) reported that a single 
intramuscular injection of 10 mg. of cortisone acetate would induce 100% 
cleft palate if injected on the 11, 12, 13 or 14th day of gestation in 
the same strain of mouse. Ingalls and Curley (1957) reported the same 
observation when hydrocortisone (cortisol) was injected instead of cor-
tisane. 
It has been established that a strain difference appears to exist 
between the A/Jax and C57bl in their sensitivity toward cortisone acetate 
or hydrocortisone. Fraser reports this difference to be variable accor-
ding to the genetic constitution of the treated mice, the dosage of cor-
tisone used and the gestational stage at which treatment is begun. The 
C57bl strain has been shown to be constitutionally more resistant to the 
cleft palate inducing effects of the cortisone: Walker and Fraser re-
ported 17-21% of fetuses had cleft palates. All previous work, which has 
been done on the C57bl strain utilized a total teratogenic dose of 10 mg. 
administered over a four day period at the rate of 2.5 mg./day. 
In as much as most of the cleft palate studies now being done 
utilizing the A/Jax strain have adopted the single dose injection tech-
nique and in order to facilitate any future comparative study with the 
C57bl strain, the purpose of this study is as follows: 
1. To determine if a single dose injection technique is feasible 
3 
for this C57bl strain of mouse. 
2. To compare the multi-injection technique with the single in-
jection technique with particular emphasis on the number of non-viable 
fetuses and resorptions as well as the number and percentage of clefts. 
3. To determine if fetal weights of the cleft animals differs 
significantly from the weights of the normal fetuses. 
4. To determine if the maternal weights during gestation are 
related to the cleft formation. 
5. To determine what percentage of clefts per animal per viable 
fetus can be obtained utilizing the single injection technique as op-
posed to the multi-injection techniques that have been utilized in the 
past. 
6. To correlate uterine position with incidence of imperfect 
fetuses. 
7. To determine what other teratogenic effects are observed in 
the fetuses which could be related to the drug. 
8. Finally, an A/Jax control group is included which will receive 
a single injection of the drug on the optimal day for cleft production 
as reported by Chaudhry (1967} to determine that cleft palate percentage 
in our laboratory is similar to that reported by other investigators. 
OIAPTER 2 
REVIEW OF LITERATURE 
A. Metabolism of the Corticosteroids. 
The secretory products of the adrenal cortex are hormones which 
resemble the lipids in their solubility properties but differ in their 
chemical structure. They are synthesized from cholesterol or from other 
intermediate products formed from acetate; these precursors are then 
transformed into active hormones by a series of enzymatic reactions occur-
ring within the adrenal cortex itself. The basic structure of the adreno-
cortical hormones is the perhydrocyclopentanophenenthrene nucleus with ~o 
additional angular methyl groups attached at carbon atoms 10 and 13, and 
an a-ketol side chain (carbon atoms 20 and 21) attached at position 17. 
The principle steroids found in the adrenal cortex include compound E 
(cortisone), compound F (hydrocortisone or cortisol), 17 hydroxycorti-
costerone and aldosterone (see Fig. 1). Cortisone (compound F) is the 
major free circulating adrenocortical hormone in human plasma. Cortisone 
has a ketone group at C-11, a hydroxyl group at C-17 and only a minute 
quantity is normally secreted each day. Hydrocortisone contains hydroxyl 
groups at C-11 and C-17. Hydrocortisone is the predominate adrenal cor-
ticosteroid and 15 to 30 mg. are secreted per day. Aldosterone contains 
an aldehyde group attached at C-13 in place of the methyl group and 
under average conditions only 150 to 300 micrograms are secreted per day. 
The secretion of adrenal cortical steroids is largely controlled by 
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Figure 1. Adrenal cortices teroids. Chemical structures of major steroids 
secreted by the human adrenal cortex. (1) Perhydrocyclopentanophenenthrene 
nucleus. (2) Corticosterone. Note that there are angular methyl groups at 
C-18 and C-19, an ~-ketol side chain (C-20 and C-21), a ketone group at 
C-3, a double bond between C-4 and C-5, an hydroxyl group at C-11; 0.5 to 
2.5 mg. of this hormone secreted per day. (3) Cortisone. Ketone group at 
C-11, hydroxyl group at C-17; minute quantity secreted per day. (4) Hydro-
cortisone. Hydroxyl groups at C-11 and C-17; 15 to 30 mg. secreted per 
day. (5) Aldosterone. Aldehyde group attached at C-13 in place of the 
methyl group; under average conditions, only 150 to 300 pg. secreted per day. 
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adrenocorticotrophic hormone (ACTH), a straight-chain polypeptide con-
taining 39 amino acids with a molecular weight of 4,500, synthesized and 
stored in the anterior pituitary gland, and released from that organ in 
response to various stimuli. 
The adrenocortical hormones exist in plasma in association with a 
specific binding globulin. Presumably, only the small fraction not bound 
to this protein is free to diffuse and act physiologically. After a few 
hours existence in plasma and tissue, these hormones are reduced by 
hepatic enzymes to a variety of C-21 metabolites and conjugated mainly 
with glucuronic acid. Both free and conjugated corticosteroid are ex-
creted with the bile into the intestine and may then be reabsorbed by 
the enterohepatic circulation. These processes render the steroids more 
water-soluble. Elimination is primarily by the kidney. Measurement of 
these urinary metabolites is a convenient way in which to assess adrenal 
function, but determinations of plasma concentration and secretory rate 
are possible. 
ACTH has only a fleeting existence in plasma; the exact pathways 
of degradation are unknown. 
Under normal circumstances, the adrenal cortical steroids are 
thought to contribute to the preservation of homeostasis by regulating 
(but not initiatin~ the metabolism of carbohydrate, protein, fat, and 
electrolyte. The regulation of biochemical processes by the cortical 
hormones is undoubtedly accomplished through the inhibition or stimula-
tion of specific enzyme systems. It cannot be stated at this time which 
7 
enzymes are primary targets, but the most important measurable effects 
of hormone action are acceleration of the conversion of glycogenic amino 
acids to glycogen in the liver (gluconeogenesis), the inhibition of the 
rate of peripheral utilization of glucose, the conservation of body so-
dium, the regulation of the rates of protein anabolism and catabolism, 
and a regulatory influence upon fat mobilization and its site of deposi-
tion. The chief hormones which influence carbohydrate, fat, and protein 
metabolism are hydrocortisone and corticosterone both are known as gluco-
corticoids. The adrenocortical hormone which is chiefly responsible for 
the maintenance of sodium and other electrolyte balance in man is aldos-
terone, a so-called mineralocorticoid. Aldosterone is unique among the 
biologically important adrenal steroids in that its secretion is affected 
only slightly by ACTH, but greatly by such stimuli as blood volume, so-
dium intake and the level of serum potassium. The glucocort1coids have 
some permissive influence upon electrolyte metabolism under physiologic 
circumstances, but the mineralocorticoids, natural and synthetic, have 
insignificant glucocorticoid activity. 
When glucocortocoids are circulating in excessive quantities, 
hyperglycemia or frank diabetes, increased protein catabolism, muscle 
wasting, osteoporosis, loss of integrity of skin and blood vasculature, 
increase in serum sodium, renal loss of potassium, edema, hypertension, 
redistribution of fat to the face and trunk, psychic disturbances, de-
creased threshold to seizures, acne, polycythemia, eosinopenia, granulo-
cytosis, lymphopenia, increased susceptibility to infection, delayed 
8 
wound healing, activation of peptic ulceration, and hirsutism may result. 
All these undesirable effects are regularly reproduced by the administra-
tion of high doses of glucocorticoid, although individual sensitivity 
plays an ·important role in determining the rapidity and degree to which 
they develop. 
Cortisol is biologically transported by the protein transcortin 
(Burton and Jeyes, 1968). The principle reactions in the metabolism of 
cortisol are oxidation and reduction changes. Conversion of cortisol to 
cortisone is readily accomplished by a reversible reaction catalyzed by 
the enzyme llB-hydroxydehydrogenase. This biotransformation can occur 
in the liver and in the lymphocytes. 
Several inactive metabolites of cortisone and cortisol with no known 
biological activity are known to exist. Some of these conversions include 
formation of tetrahydrocortisol in the liver, substance E of Reichstein, 
substance U of Reichstein, dehydrocortisol, pregnane-liB, 17-dione, and 
4-androstene-llB-ol-3. These biotransformations are the results of com-
binations of oxidations, ·reductions, and saturation of the double bonds 
of hydroxyls, ketones, and double bonds characteristic of cortisol, These 
metabolites can then be made water-soluble through conjugation mainly in 
the liver, and secondarily in the kidney. Conjugation with glucuronic 
acid forms glucuronides while conjugation with sulfate produces sulfate 
esters. Both water-soluble conjugates can then be excreted through the 
kidney. The unconjugated metabolites will remain in the blood serum. 
B. Cleft Palate Induction in Animals. 
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In recent years the role o~ congenital malformation. as one of the 
leading causes of infant mortality and morbidity has been recognized. 
Whenever a medi·cal p·robletn· exists, it is of value ·tO be able to reprodu.ce 
the pathologic phenomena in animal experiments. Congenital malformations 
have been produced in lower classes of animals for nearly a century but 
because mammals have so completely different a prenatal maternal-off-
spring relationship suCh experiments did not satisfy those interested in 
the origins of congenital malformations in children. The first terato-
logic method practiced in mammals, which dates back to the first decade 
of this century, was the administration of x-rays to the pregnant mother 
(Kalter, 1957). 
Approximately four decades ago much interest in congenital malfor-
mation was aroused when it was shown that these malformations could be 
induced by dietary deficiencies in pregnant animals. Specifically Hale 
(1933) showed that malformations could be produced in pigs with vitamin 
A deficiencies. Since then several investigators have produced malfor-
mations in test animals utilizing a variety of agents. 
Corticosteroid hormones and ACTH have been administered to pregnant 
animals of several species by a large number of investigators. Various 
workers using rats, rabbits and monkeys, usually of unspecified origin, 
gave different amounts of cortisone acetate, ACTH, or other cortico-
steroids, intramuscularly or subcutaneously, for selected periods start-
ing at various times before and during gestation. Resorption and/or ab-
ortion occurred almost invariably when treatments with large doses of 
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hormone were begun during the middle third of pregnancy, but the occa-
sional survivors were normal. The effect of lengthy treatment with cor-
tisone on fetal distribution was not minimized or blocked by adrenalectomy 
of the pregnant female but the influence of ACTH in reducing litter size 
and fetal weight was prevented by maternal adrenalectomy. 
Walker and Fraser (1957) working with mice, produced resorptions 
by administering intraembryonic injections of about .25 mg. of cortisone 
between 12 and 14 days after conception. But when injection was made 
into the embryonic sac, cleft palate resulted. However, intra-amniotic 
injections of cortisone vehicle also produced cleft palate. This result 
led the authors to believe that effect was due to the observed leakage 
of amniotic fluid through the hole made by the hypodermic needle, whiCh 
caused a reduced hydrostatic pressure in the amnion, allowing the con-
tracting uterus to press the embryo's head onto its chest, 1odging the 
tongue between the palatine processes and thus preventing their movement. 
This study was repeated by Trasler et al (1956) who, on day 13 of ges-
tation, merely inserted a hypodermic needle through the uterine wall into 
the amnion, but injected nothing. This procedure also produced cleft 
palate. 
Congenital malformations in offspring of cortisone-treated pregnant 
animals were first reported by Baxter and Fraser (1950), who produced 
cleft palate without cleft lip in mice by such treatment. By administra-
tion of various doses of the hormone (from 0.625 to 10 mg. per day given 
for 2-4 successive days beginning different times during the second third 
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R!.Pr~gnancy) to several ~trains and types of mice, Fraser and Fainstat 
(1951) established that the frequency of cleft palate produced in the 
offspring varied with the dose given, time treated, and strain used. 
The highest incidences of the malformation compatible with minimum fre-
quency of resorption were produced by 2.5 mg. cortisone acetate per day 
given for 4 successive days beginning 11 days after conception. This 
schedule produced almost 100 per cent affected young in the A/Jax strain, 
about 20 per cent in the C57bl/6 strain and about 80 per cent in the 
DBA/I strain. 
Fraser et al (1954) suggested two different mechanisms that may be 
operational in causing induced clefts: one which causes a delay in the 
rotation of the palatal shelves before palatal closure, and one which 
causes a breakdown in previously fused palatal tissues. 
In 1954, Walker's theory was that a delay in the average time and 
rate at which shelf movement occurred was the primary cause of induced 
clefts. He cited as evidence the fact that he observed many embryos in 
which one palatal shelf had horizontalized while the other remained ver-
tical. This finding was not often encountered in untreated embryos 
according to Walker. He also found that there was no significant dif-
ference in the size of the palatal shelves in treated and untreated ani-
mals prior to the time of palatal closure. He did feel that fusion of 
the shelves is necessary to promote growth of the shelves beyond the size 
prior to closure. 
Walker further suggested in 1954 that there would be a decrease in 
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the force available to cause shelf movement if cortisone acted upon the 
shelves directly. Such decrease in available force might be due to: 
1. Inhibition of fiber formation. 
2. Inhibition of acid mucopolysaccharide synthesis. 
3. Change in the pattern of tissue arrangement, i.e., fiber 
mucopolysaccharides. 
Larsson (1961-1962) upheld the idea of Walker and Fraser (1956) 
that shelves in cleft animals are retarded in horizontalization and that 
the formation of substances necessary to produce the force for horizon-
talization is inhibited by cortisone, i.e., acid mucopolysaccharides. 
He demonstrated that cortisone injection lowers the amount of sulfate 
incorporated into the mouse embryo acid mucopolysaccharides. 
Kalter (1957) enumerated some of the factors which determine the 
frequency of appearance of animals with clefts in a cortisone-treated 
litter. Among these were: gestation time, maternal genotype, dose of 
cortisone, strain of mouse, fetal genotype, maternal weight, and fetal 
weight. Kalter also showed that there were fewer complete fetal resorp-
tions in untreated litters than in cortisone-treated litters. Treated 
litters had 30% fewer animals, and the individual cleft palate newborn 
weighed less than his normal counterpart. A lower-frequency of clefts 
was noted where there were heavier mothers or more advanced parities. 
Kalter (1954) made a study of the inheritance of susceptibility to 
the teratogenic action of cortisone, first, by treating A/Jax and C57bl 
females that were crossed to males of the other strain. In this way Fl 
13 
hybrid fetuses of identical genetic composition (aside from the sex chro-
mosomes) carried by both types of pure strain females were subjected to 
the influence of cortisone. The frequency of cleft palate in suCh hy-
brids of identical genetic constitution was different when they were 
carried by A/Jax females than if carried by C57bl females. Hybrids from 
A/Jax females had an incidence of 43.5 per cent cleft palate and those 
from C57bl females had 3.7 per cent, indicating a potent maternal in-
fluence operating on the teratogenic efficacy of cortisone. Fl females 
of reciprocal crosses between the A/Jax and C57bl strains were then back-
crossed to A/Jax males and treated. The frequencies of malformed young 
from both types of Fl mothers were about the same (25%) , eliminating the 
possibility that the maternal influence mentioned above was due to a cyto-
plasmic factor. Further analysis showed that the genetic composition of 
both mother and fetus influenced the cortisone effect. 
In an investigation of the food consumption of pregnant cortisone 
treated mice, Kalter (1955) , showed that the hormone caused a significant 
increase in food eaten by pregnant mice and proved that the teratogenic 
effect was not a consequence of decreased food intake. 
Fainstat (1954) has proved that cortisone is teratogenic in at 
least one species other than mice. In this study, rabbits of commercial 
origin were given 25 or 30 mg. of cortisone intramuscularly per day for 
4 successive days beginning the 14th or 15th day of gestation; of 35 
offspring, 17 had cleft palate. 
Several other steroid hormones have been administered to pregnant 
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mice by Fraser and colleagues. Hydrocortisone was found to be a potent 
cleft palate-inducing agent (Kalter and Fraser, 1952). This was con-
firmed by Ingals and Curley (1957) • ACTH also produced cleft palate. 
Strain A females were given 5 mg. ACTH every 6 hours for 2 or 3 days 
beginning the 13th day of gestation, and cleft palate was induced in some 
of the young. Injections of 11-desoxycorticosterone were without effect 
on embryonic development in mice by Burdick, Baird and Rogers (1954) and 
this substance produced "some embryonic malformations ••••• in embryos re-
covered at term from treated ovariectomized pregnant hamsters (Tedford, 
Various studies were undertaken and analyses made to further evalu-
ate some of the residual sources of variability of susceptibility to-the 
cleft palate-inducing property of cortisone. It was first found that a 
decrease in frequency of cleft palate occurred in the offspring of suc-
cessive litters of treated pregnant mice (Kalter and Fraser, 1953). By 
treating primiparous mice, the weights and ages of which varied widely 
it was found in members of litters of uniform parity that the cleft pal-
ate frequency was significantly inversely associated with maternal 
weight, but not with maternal age (Jost, 1951). In these three studies 
mice of three different genetic constitutions were used and the average 
frequencies of cleft palate were all different from one amother, but the 
regression coefficients of maternal weight on cleft palate frequently were 
approximately the same in all the studies, indicating that the level of 
protection afforded by increased maternal weight against cortisone-
15 
induced cleft palate may be a constant. Finally, it was found (Kalter, 
1957), that affected offspring were significantly ligher than were their 
siblings with normal palates from cortisone-treated mothers. A decrease 
in weight of young with cleft palate was also noted in the offspring of 
cortisone-treated rabbits (Fainstat, 1954). An embryological study was 
made of palate closure in control and cortisone-treated mice of three in-
bred strains (Walker and Fraser, 1957). These studies revealed that in 
control animals the palate closed on the average at an earlier develop-
mental age in C57bl fetuses than in A/Jax fetuses, with DBA mice being 
intermediate and claimed that the strain difference between resistant 
C57bl and susceptible A/Jax mice in response to cortisone was due to the 
earlier closing of the palate in the C57bl strain. Clark (1956) in his-
tological studies of the embryonic palate observed stainable elements 
that increase in concentration with advancing stages of palate closure." 
Control A/Jax fetuses had lower concentrations of these elements than 
control C57bl's, and both types of treated fetuses showed less stainable 
material than controls, with the concentration in treated A's less than 
in treated C57bl' s. Since relatively few C57bl and many A/Jax young show 
cleft palate after cortisone, Clark proposed that the stainable material 
was elastin and may be the physical basis for palatal shelf movement, 
this being normally present in A/Jax mice nearer a critical level, and 
hence less easily brought below the threshold in the resistant than in 
the susceptible strain. 
In rats, cortisone has repeatedly been found not to be teratogenic, 
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but a potentiating effect of cortisone on the teratogenic action of 
hypervitaminosis A was recently reported (Woollam and Millen, 1957). 
Loevy (1962) did not feel that the tongue played an active role in 
cleft formation, nor was it a major consideration in horizontalization. 
She further felt that the role of the connective tissue in cleft develop-
ment has been overemphasized. She based her findings upon an investi-
gation in whiCh she injected 1.25 mg. of cortisone daily from the eleventh 
to the fourteenth day in Strain A mice and achieved 100% cleft formation. 
Loevy attributed cleft formation to a basement membrane which cannot be 
penetrated by connective tissue when the shelves are continuous and ready 
to fuse. 
It has not yet been determined exactly how cortisone acts to induce 
the formation of cleft palate. It is possible that there is an inter-
mediate action elsewhere in the fetus or mother, or it may act directly 
on the palatine shelves. 
Cortisone is not found in adrenal venous blood or peripheral blood. 
Its function seems to be directed as a precursor for hydrocortisone 
which is found in the peripheral circulation. Cortisol exhibits an anti-
inflammatory action probably due to its ability to suppress the cell's 
activity in producing the chemical agents responsible for inflammation. 
_It is also known to elicit a mild hyperglycemia and in improvement in 
overall capillary tone, resulting in diminished exudation of plasma into 
the tissues. Cortisone also causes a decrease in circulating eosino-
phils, a decrease in lymphocytes and an increase in the total white cell 
I 
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count due to an increased number of polymorphonuclear leukocytes (Krantz 
and Carr, 1961). 
Cortisone aids in the regulation of fat, protein, and carbohydrate 
metabolism. It is also responsible for polycythemia (an increase in the 
number of red blood cells) and for a decrease in lymphoid tissue mass. 
Cortisone can produce a lymphocytopenia according to Goodman and Gilman 
(1965). 
Dougherty et al (1961) stated that cortisol in tissue culture causes 
a "pulling in" of the processes of the fibroblasts resulting in an epi-
thelioid-appearing cell which develops numerous vacuoles filled with redu-
cing substances. Pinocytosis is completely absent, and the epithelioid 
cells persist intact in spite of enormous damage to neighboring fibro-
blasts even when the tissue is extensively infiltrated by polymorpho-
nuclear leukocytes. The epithelioid fibroblasts have been cinemicrogra-
phically shown to be quite inactive in their movement. 
Dougherty stated that the anti-inflammatory action of corticoster-
oids is a focal one and does not depend upon metabolites created by dis-
tant sites. He also felt that the influences which cortisol exerts on 
connective tissue are primarily due to modofications in fibroblast func-
tion. The fibroblast is the cell responsible for the majority of struc-
tures present in connective tissue, i.e., ground substance matrix and 
fibers. 
Although the biologically active form of the steroid is cortisol, 
Dougherty feels that cortisone is reversibly transformed to cortisol and 
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hence acts as a potential reserve for cortisol when it is needed. 
It was found (Bollough 1952, Sayeed 1962) that cortisone can sup-
press mitosis although it is unlikely that this is one of cortisone's 
fundamental actions. Roberts (1952) and Mott (1968) concluded that 
maternal cortisone injections affected the palatine shelves of A/Jax 
mice by suppression of mitosis, thereby causing a deficiency in the 
number of cells with a subsequent decrease in the amount of intercel-
lular substance. 
Layton (1951) stated that high doses of cortisone inhibit the 
synthesis of chondroitin sulfate in connective tissue. Cavallero and 
Braccine (1951) found that metachromatically stainable material had prac-
tically disappeared from the interfibrillar ground substance while Lattes 
et al (1953) also stated that there is a reduction in the metachromasia 
normally seen suggesting that the mucopolysaccharides of cortisone-
treated tissue do not undergo the same chemical changes as in untreated 
specimens. 
Larsson (1962) also felt that cortisone interferes with the syn-
thesis of the usual sulfated mucopolysaccharide content of connective 
tissue, and Jacobs (1966) concluded that there is more water present in 
the palates of cortisone-treated embryos and that this edema is most 
striking during the critical period of palate closure. Jacobs attributed 
this edema to a decreased level of sulfated mucopolysaccharides in the 
shelf mesenchyme. 
In 1953, Paff and Stewart noted a reduction on the number of mast 
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cells with cortisone treatment, while Birko (1953) found that it inhi-
bits both hyaluronidase and streptococci. 
In skin wounds, Ragan et al (1949) found the development of granu-
lation tissue was markedly delayed by cortisone. Kivirikko (1963) stated 
that cortisone caused an increase of hydroxyproline and a decrease in the 
amount of alkali-soluble and neutral-salt soluble collagen in the chicken 
and attributed to cortisone the ability to alter collagen metabolism. 
Fraser et al (1967) determined that the administration of cortisone 
to a pregnant female mouse caused a reduction in the volume of the amni-
otic fluid (oligohydramnios) of the mouse embryo at the time of palatal 
closure, but the amount of the decrease was shown to be exactly the same 
in normal embryos as in embryos with clefts. He therefore concluded that 
the amniotic fluid reduction cannot be the factor that determined whiCh 
co-investigators thought originally that the reduced volume of amniotic 
fluid might cause a constriction of the embryo with subsequent flexion 
of the neck pressing the lower jaw against the chest, thus jamming the 
tongue between the palatal shelves and preventing their closure. 
Kerppala and Pitkanen (1960) learned that cortisone inhibits the 
uptake of oxygen by rat liver mitoChondria, reduces the activity of the 
enzyme cytochrome oxidase, and uncouples the process of oxidative phos-
phorylation which occurs in the mitochondria. 
DeVenuto et al (1968) by the use of cell fractionation and steroids 
which were labeled with radioactive tritium and Carbon-14, showed that 
corticosterone and cortisone exhibit a definite interaction with the 
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nuclear and mitochondrial fractions of rat liver cells. 
Nasjleti et al (1967) administered a single intramuscular 10 mg • 
• injec·tion of tritium-labeled cortisone to pregnant female A/Jax mice at 
12~ days of gestation. Blood samples were withdrawn from the animals at 
various time intervals while they were still alive and these were analy-
zed by liquid scintillation as were various maternal tissues after the 
animals were sacrificed. Autoradiograms and routine hematoxylin and 
eosin slides were prepared from the embryos and placentas which were ob-
tained by Caesarean section. The investigators found that the maternal 
plasm radioactivity reached a peak 40 minutes after the injection of the 
tritiated cortisone and that radioactivity could be found in the adrenal 
gland, liver, kidney, spleen, and thymus as well. Autoradiographic 
examination of the placentas and embryos revealed that labeling was pre-
sent on the maternal side of the placenta and in the blood channels of 
the embryonic liver and heart 5~ hours after the injection was admini-
stered. Nasjleti (1969) was not able to find labeling in the embryonic 
p~late or maxillary tissue. 
Levine, Yaffe and Black (1968) compared the fetal uptake of radio-
active cortisol in A/Jax (cleft palate susceptible) and C57 Black Mice 
(cleft palate nonsusceptible). Subcutaneous injections were made on day 
11 of gestation with 2.5 mg. of cold carrier. The mice were sacrificed 
at intervals of 30, 60, 120, and 240 minutes. 
Levine et al reported a similar rate of uptake of radioactivity in 
both strains but a significantly higher amount in the A/Jax fet.uses. He 
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was able to show that the two strains had similar disappearance rates of 
the labeled cortisol and the concluded difference in susceptibility be-
tween the two strains was not due to variation in placental transport but 
due to differences in metabolism and/or binding by the fetuses. 
Beitins, Kowarski, Shermeta, Delemos, and Migeon (1970) infused 
three pregnant ewes with C-cortisol while simultaneously infusing their 
fetuses with 1ff-cortisol in utero. The fetuses were infused by catheters 
through the common carotid artery, and a catheter was placed into the 
external jugular vein for withdrawing blood samples. The ewes had cath-
eters for infusion placed in the external jugular vein while blood samples 
were drawn from the opposite jugular vein by venipunctures. After surgi-
cal placement of these catheters and the animal recovery, the double con-
stant infusion of the radioactive cortisol began. Blood samples (mater-
nal and fetal) were withdrawn every 15 minutes for three hours. The up-
take of the fetal cortisol in the maternal blood was measured and cor-
rected relative to the blood flow. A similar treatment of data from the 
fetal blood samples was made. Beitins et al reported a net transfer rate 
of the hormones across the placenta in both directions but of different 
magnitudes. There appeared to be a significant barrier for the movement 
of maternal cortisol to the fetus, thus allowing the fetus to maintain 
lower concentrations of cortisol for independent homeostatic regulation. 
Marks (1969) reported a significant amount of label on autoradio-
graphs in the fetal palatine processes on the twelfth day of gestation 
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in A/Jax mice. He injected 2.5 mg. of unlabeled cortisone acetate in-
tramuscularly thirt~ minutes prior to a second injection of tritiated 
cortisol. The animals were sacrificed five hours after the second in-
jection. Marks reasoned that the first injection of cortisone-acetate 
would overload the receptors for the metabolism of cortisone which would 
allow the tritiated cortisol to circulate freely and therefore increase 
its chances in finding its way to the fetus. Dodds (1971) found that 
this "loading dose" had just the opposite effect. 
Marks, Schmitz (1970) also reported a significantly higher grain 
count in the palatal processes in fetuses taken from the left uterine 
horn than those from the right. Schmitz also reported a significant 
variation between placental and fetal tissues obtained from different. 
mothers, explaining this variation by differences in maternal vascularity. 
Dodds (1971) compared the uptake of tritiated cortisol when injec-
ted in A/Jax mice on the 12th day of gestation with a 2.5 mg. cortisone 
acetate "loading dose" and without a "loading dose". Dodds reported no 
significant variation in the different maternal tissues (except higher 
in the liver) and no variation in the various fetal tissues. The mater-
nal tissues were significantly higher than the fetal tissues. He also 
found that the loading dose hinders rather than improves the uptake of 
label. A comparison of placentas from the right and left sides were 
reported to have no significant difference in labeling. 
Waddell (1971), using wholebody autoradiograms, studied the dis-
tribution of 14c-cortisone in pregnant A/Jax mice. He found little 
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variation in the autoradiograms between the different stages of gesta-
tion. He reported the highest concentration of radioactivity in the 
maternal bile, liver, intestinal contents, and the kidney. At all time 
intervals, the concentrations of radioactivity in the fetuses were lower 
than the pregnant female. The fetal tissues reportedly showed a rather 
even distribution with no greater amounts in the palatal buds. He did 
show accumulation of radioactivity surrounding the embryo in all gesta-
tion periods past twelve days. With thin-layer chromatography of the 
uterine fluid superimposed on x-ray film, he concluded that the yolk sac 
is the cause of the difference either from a metabolic or an absorptive 
standpoint. 
In a comparative study between A/Jax mice and C57bl mice (Reminga 
and Avery, 1972) the differential binding of l4c-cortisone was examined. 
On day 12.5 of gestation, each pregnant mouse was administered 2.5 mg. 
of cortisone acetate intraperitoneally plus 5uCi of l4c-cortisone. Thirty 
minutes after the injection, the maternal liver, fetuses, and placentas 
were removed for the study. 
Spain (1973) using twenty-one pregnant A/Jax mice injected a sol-
ution of 50 uCi of 3H-cortisol and 10 mg. of cortisone acetate on day 12 
of gestation. Four animals were sacrificed at each of the following 
time intervals after injections: 0.5 hour, 1.0 hour, 1.5 hour, 2.0 hours, 
3.0 hours and one animal at 6.0 hours. The maternal liver, adrenal, 
brain, placenta, yolk sac and the fetuses in three segments, torso, jaws, 
and the remainder of the head were removed for analysis. Each tissue was 

CHAPTER III 
METHODS AND MATERIALS 
A. Mice. 
Segregated quantities of two strains of mice were obtained from 
Jackson Laboratory in Bar Harbor, Maine. A total of 60 female strain 
C57bl and 10 female strain A/Jax were used in this study. These mice 
I were obtained at the age of 12-15 weeks and used for approximately 7 
I 
months. Comparably aged males of the same strains were provided for 
mating. 
' 
B. Feeding and Environment. 
An environmental control room in the animal care facility was used~ 
where constant temperature and humidity was maintained. A day/night 
cycle was maintained by a clock mechanism whiCh automatically turned the 
lights on at 6:00 a.m. and off at 6:00 p.m. Standard Purina Rat Chow 
and tap water were given ad libitum. 
C. Mating. 
Prior to mating of the mice, all females were placed in separate 
cages for conditioning to the environment, for one month. At the end of 
this period, mating commenced. One male was placed in a cage with a 
single female at 6:00 p.m. The female was then checked for the presence 
of a vaginal plug at 8:00 a.m. on the following morning. At this time 
the males were removed from the cage of the female and segregated until 
6:00 p.m. when they would again be placed with the female for mating. 
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When a vaginal plug was found, the mouse was weighed and that day recorded 
as day zero. Since ovulation usually takes place shortly after midnight 
(Grunebery, 1952) and copulation any time afterwards, an unavoidable error 
of up to 8 hours must be realized. The mouse was again weighed at 8:00 
a.m. on day 10. If a weight gain of two grams or more was measured , the 
mouse was considered pregnant and placed in one of seven groups which will 
be described. 
D. Group Assignment. 
Pregnant mice were assigned at random to each of the seven experi-
mental groups. Group A consisted of two C57bl mice which were weighed 
and given a 10 mg. injection of normal saline on the 12th day of gesta-
tion. This control group of pregnant mice was used to compare the effect 
of cortisone on fetal and maternal weights. 
Group B consisted of ten C57bl mice which were weighed and given 
2.5 mg. of cortisone at 12:00 noon for a four day period commencing on 
day ten. 
Group C through F consisted of ten C57bl each which received a 
single 10 mg. injection of cortisone on days 10, 11, 12 or 13 of gesta-
tion respectively. 
Group G consisted of ten A/Jax mice whiCh were given a single dose 
of 10 mg. of cortisone on the 12th day of gestation. 
E. Disection and Inspection. 
On the 18th day postconception, the animals were weighed and sacri-
ficed by a sharp blow to the occiput followed by immediate decapitation. 
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The fetuses were delivered through Caesarean section and the number and 
position of the fetuses were noted. They were then weighed and the 
viable, non-viable and resorbed fetuses were recorded. A gross micro-
scopic dissection was then performed on all fetuses and all abnormalities 
were recorded. The palate was more closely examined and classified as 
normal or cleft. 
The data on the frequency of cleft palate, cleft lip and palate, 
viable, non-viable fetuses and resorptions were analyzed by chi square 
tests. Fetal and maternal weights were analyzed by the T-test. In cal-
culating the frequency of cleft palate fetuses the cleft lips were omit-
ted as this latter abnormality occurs spontaneously in both strains of 
mice used. 
F. Drugs and Route of Administration. 
The drug used in this study was an aqueous solution of cortisone 
acetate manufactured by Upjohn and supplied in a multidose vial contain-
ing 25 mg./cc. A total of 0.4 cc. or 10 mg. was aspirated into a 1 cc. 
tuberculin syringe and administered to each test animal in Groups C 
through G. One half of the solution was injected intramuscularly into 
the hamstring muscle of each leg being careful to aspirate first and 
inject slowly. Group B received 0.1 cc. (2.5 mg.) total per day for four 
consecutive days. Group A was the control group and received on day 12 
of gestation a 0.4 cc. (10 mg.) injection of sterile normal saline in-
stead of cortisone acetate. 
I 
I 
I 
I 
Right Horn 
UTERUS 
Left Horn 
Fetal Resorption 
Fetal Positions in Uterine Cervix 
FIGURE 3 
Cll.APTER IV 
FINDINGS 
Table 1 shows the test results of 66 mice injected with Cortisone 
Acetate, arranged by day of gestation and dose of the hormone. Figure 
2 represents the graphical distribution of normal and cleft palates 
among the 425 fetuses. 
Group G, consisting of A/Jax mice, shows the highest number of 
clefts. 
In the C57bl mice, Group B, (2.5 mg./4 days) was obviously more 
affected by the cortisone than were Groups A (control receiving 0.4 cc. 
normal saline) , C (receiving 10 mg. on the lOth day of gestation) , D 
(receiving 10 mg. on the 11th day of gestation) , E (receiving 10 mg. on 
the 12th day of gestation), F (receiving 10 mg. on the 13th day of ges-
tation). This was shown by the unusually high percentage of cleft pal-
ates produced in this resistent strain of mouse and also by the high 
number of resorptions and non-viable fetuses. Group C (10 day) and 
Group D (11 day) responded with 17 and 21% cleft production respectively 
to the effects of the drug although Group C exhibited a high percentage 
of resorptions. 
Other malformations observed were cleft lip associated with cleft 
palate. Four instances of this combination was observed, one of these 
was seen in a fetus whose mother was in Group B (2.5 mg./day) and received 
four injections over· a four day period commencing on day 10 of pregnancy. 
28. 
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This was a unilateral cleft palate and cleft lip. Three instances were 
observed in the A/Jax group (G) that was given a single dose of 10 mg. 
of cortisone. Two of these fetuses had unilateral cleft lip associated 
with a midline cleft palate and the other fetus demonstrated a bilateral 
cleft lip associated with a unilateral cleft palate. 
One monster was observed in the day 13 group (Group E). This 
fetus showed fusion of the lips and lacked one eye and pinnae. 
No attempt was made to find additional congenital malformations 
other than ~sing gross microscopic inspection of the external fetus. It 
is pertinent to point out that cortisone injections during pregnancy of 
C57bl resulted sometimes in maternal death a few days afterwards. More 
often, however, it produced early and late embryonic deaths within litters 
and of entire litters. 
Maternal weights were recorded on the morning that the vaginal 
plug was observed and again at the time of drug administration once preg-
nancy had been established. A final maternal weight was recorded just 
prior to sacrificing. Final weights of all mothers were compared utili-
zing the T test to see if any significant differences could be shown be-
tween weights of control animals, maternal weights of treated litters 
with no cleft offspring and maternal weights of treated animals producing 
fetuses exhibiting cleft palates. Weight differences were determined to 
be nonsignificant (P<.os). 
Fetal weights were also recorded as were uterine positions of def-
ective offsprings and evaluated for statistical significance. It was 
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found that the weights of fetuses obtained from animals in the control 
group (A) were significantly higher than weights of fetuses obtained 
from non-cleft animals (t = 10.76, P( .001) and also significantly higher 
than the weights of fetuses obtained from mothers which showed cleft 
fetuses (t = 11.79, P( .001). No difference, however, could be shown 
between weights of fetuses obtained from treated animals showing clefts 
and treated animals producing cleft free litters. Uterine position was 
evaluated with respect to location of cleft or resorbed fetuses in order 
to determine if either the distal or proximal position was more suscepti-
ble to cleft frequency or that left uterine horn or the right was more 
vulnerable. Figure 3 illustrates how uterine positions were labeled. 
The various possible positions were statistically evaluated by chi square 
and found to be insignificant. Uterine position could not be correlated 
with either cleft formation or frequency of resorption. 
Finally in order to determine if any statistical difference could 
be shown between the multi-injection technique and the single injection 
teChnique, the data was summarized and evaluated as to cleft versus non-
cleft and viable versus non-viable and subjected to chi square analysis. 
The data is shown i~ Table 1. The results show that if the 10 mg. single 
injection technique is used on day 10 or 11 of pregnancy in the C57bl 
.strain of mouse that there is no significant difference when compared to 
the 2.5 mg./day multi-injection teChnique. 
Mice which were administered cortisone on day twelve (Group E) 
were considerably different both in fewer clefts (chi square= 7.3) and 
,,1 
;,,'1 
Ill' 
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fewer resorptions (chi square = 11.4, P ( .001) when compared to the 2. 5 
mg./day group. Resultant litters from Group F (day 13 injection) exhi-
bited even greater differences with a chi square= 17.5 for clefts and 
a chi square = 20.4 for resorptions, (P< • 001) when compared to the same 
group B, 2.5 mg./day. 
1: 
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CHAPTER V 
DISCUSSION 
A ten milligram injection of cortisone acetate had considerable 
tetratogenic effect on the developing embryo of the C57bl pregnant 
mouse. The effect of the drug administration was most profound when 
given approximately 48 hours before palate closure as previously noted 
by Chaudhry (1967). When a ten milligram dose was given on day eleven 
of gestation, the results consistently produced around 20% cleft palate 
in this previoUsly defined resistent strain (Walker, 1957). The findings 
corroborate those of Fraser and his colleagues, who injected inbred 
strains of mice with daily doses of cortisone for a period of four days 
and demonstrated its capacity for inducing cleft palates in the young. 
Our experiments show that this four day regimen can be narrowed to a 
single day with a single dose and further that the response is dependent 
upon the timing and dose of cortisone given. There is no question that 
genetically determined susceptibility also influences expression of the 
acquired defect; but genetic susceptibility is shown to be one of mul-
tiple factors that contribute to the genesis of cleft palate in unborn 
mice. The data shown in Table 1 narrow markedly the apparent discrepancy 
in timing between the cortisone induced disturbances. Palates of embryos 
in the C57bl strain of mice normally close about the 14th or 15th day as 
opposed to the 16th day for the A/Jax strain (Kalter, 1952). Thus it 
would be expected that this earlier maturing mouse would behave as it has 
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been shown and exhibit the teratogenic effects one to two days and 
earlier than its highly susceptible counterpart, the A/Jax mouse. This 
so called incubation period of 48 hours immediately preceeds the criti-
cal period of accelerated differentiation and fusion when the embryo 
appears to be in a highly susceptible state and ready to depart from 
normal ontogenetic sequences of morphogenesis. 
From the observed incidence of cleft palate, it is quite obvious 
l that cortisone in a 10 mg. dose is equally as effective as a teratogenic 
l agent when administered on day 10 or 11 of gestation. However this effect declines sharply when the drug is given on the 12th or 13th day 
of pregnancy. This study indicates a trend toward a higher percentage 
of clefts in groups subjected to the four day regimen of injections 
(2.5 mg./day) although no statistical difference could be shown between 
drug administration regimes. While animals were randomly selected for I, 
II 
the other groups, apparently significantly younger and lighter mothers 
were used for multi-injection group B. This could probably account for 
the relatively higher percentage of clefts and resorptions in this group 
(Kalter, 1955). 
The data further suggest that there is a significant reduction in I ,I 
fetal weights of animals borne by cortisone treated mothers. It was 
shown that not only are cleft fetuses significantly lighter than control 
but also non cleft fetuses of cortisone treated mothers are significantly 
lighter than the normal palated fetuses in the control group. From this 
fact we suggest that the cleft manifestation may partly stem from a more 
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general stress imposed on the maternal environment and not solely by 
direct action of cortisone against the affected fetus. 
From the foregoing it can be seen that congenital malformations 
are but one manifestation of pathology inflicted by cortisone injections. 
Such experimental methods are capable of inducing more severe disturbances 
such as abortion, fetal resorption, or neonatal death. But while it is 
relatively easy to interrupt pregnancy by environmental interferance, it 
is more difficult to obtain young with congenital malformations, since 
this requires an experimental arrangement that permits damaging the 
embryo without killing it. To achieve such balance, the teratogen, its 
dose, and timing, must be coordinated. 
CH.APTER VI . 
SUMMARY AND CONCLUSIONS 
Cortisone acetate was administered as a teratogenic agent to 5 
groups of C57bl mice and one group of the A/Jax strain of mice. An 
additional C57bl group served as a control. Each test group was injected 
on a single day of pregnancy except for one group which received a four 
day regimen of injections, equal in amount to that given the other groups 
on a single injection. These injections were given on the lOth, 11th, 
12th and 13th day of gestation for the purpose of determining on which 
day the agent was most effective in producing cleft palate. 
1. The eleventh day of pregnancy proved to be the most feasible 
from the standpoint of percentage of clefts produced, per viable fetuses 
and number of resorptions suffered. 
2. It was determined that fetal weights of treated animals were 
significantly lighter than weights of control litters. 
3. Maternal weights were determined to be unrelated to cleft 
formation. 
1: 
j! 4. It was shown that in the C57bl strain, a single injection drug 
administration can adequately replace a multi-injection technique spread 
over a 4 day period if the single injection is done on the eleventh day. 
5. Occurrances of malformation are unrelated to uterine position 
of the fetus. 
The induced defect was always in the midline and not associated 
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with the cleft lip. The four observed occurrances of cleft palate with 
cleft lip was 1%, a finding in agreement with other investigators 
(Hackman and Brown, 1972). This defect resembled the inherited cleft 
which to the author's knowledge has never been produced to date by 
known teratological methods. 
TABLE 1 •. Results of Cortisone Acetate Injection in 66 Pregnant Mice ~ 
Percentage of 
Injection Number of Number Resorptions Viable Fetuses 
Day(s) of Litters Dose Number of and Non-Viable Number of with Cleft 
Grou£_ Gestation Examined Administered Fetuses Fetuses * Clefts ** 
Palate 
Control 0.4 cc. 
A (12 day) 10 Sterile Saline 55 4 0 0 
10 mg. 
10, 11 (2. 5 mg. /day) 
B 12, 13 10 (0.1 cc.) 59 27 14 44% 
10 mg. 
c lOth day 10 (0.4 cc.) 65 36 5 17% 
10 mg. 
D 11th day 10 (0.4 cc.) 57 10 10 21% 
10 mg •. 
E 12th day 10 (0.4 cc.) 59 10 8 16% 
10 mg. 
F 13th day 10 (0. 4 cc.) 77 12 7 11% 
A/Jax 10 mg. 
G 12th day 6 (0. 4 cc.) . 53 15 36 98% 
* Significant chi square comparisons between groups for non-viable fetuses (P 0.05) 
A vs. B, A vs. C, A vs. G, B vs. D, B vs. E, B vs. F, C vs. D, C vs. E, C vs. F, C vs. G. 
** Significant chi square comparisons between groups for clefts (P .OS) 
A vs. B, A vs. C, A vs. D, A vs. E, A vs. F, A vs. G, B vs. E, B vs. F, B vs. G, C vs. G, D vs. G, E vs. G, F vs. G. 
~ 
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